Alphabet Inc
Alphabet Inc's Alphabet Inc holds 26 U.S.-equity positions worth $4.0B (SEC 13F, Q1 2026). Top positions: CME Group Inc. 25.6%, Planet Labs PBC 24.5%, AST SpaceMobile, Inc. Class A Common Stock 18.5%. 13F-replication return is +155% over 3 years (+76 pts vs the S&P 500) — a replicated, non-audited figure.
Holdings
| Stock | % of portfolio | Shares | Value | Latest activity | Avg buy price | Current price | Date |
|---|---|---|---|---|---|---|---|
| CME CME Group Inc. | 25.6% | 3.5M | $1.0B | NEW (+3.5M) | $295.35 | $266.09 (−10%) | 2026-03-31 |
| PL Planet Labs PBC | 24.5% | 35.2M | $985M | ▲ 10% (+3.3M) | $6.18 | $16.27 (+163%) | 2026-03-31 |
| ASTS AST SpaceMobile, Inc. Class A Common Stock | 18.5% | 8.9M | $741M | — | $22.74 | $58.00 (+155%) | 2026-03-31 |
| RVMD Revolution Medicines, Inc. Common Stock | 8.0% | 3.3M | $320M | ▼ 1.6% (−53K) | $28.69 | $207.73 (+624%) | 2026-03-31 |
| ARM Arm Holdings Plc | 7.4% | 2.0M | $297M | — | $53.52 | $291.95 (+445%) | 2026-03-31 |
| FRSH Freshworks Inc. Class A Common Stock | 3.2% | 16.2M | $130M | — | $15.89 | $13.11 (−18%) | 2026-03-31 |
| PATH UiPath, Inc. | 1.9% | 7.0M | $78M | — | $17.56 | $13.09 (−25%) | 2026-03-31 |
| TEM Tempus AI, Inc. Class A Common Stock | 1.8% | 1.6M | $70M | — | $35.00 | $81.35 (+132%) | 2026-03-31 |
| PAYP Paypay Corp | 1.7% | 3.1M | $67M | NEW (+3.1M) | $21.34 | $15.73 (−26%) | 2026-03-31 |
| GTLB GitLab Inc. Class A Common Stock | 1.5% | 2.7M | $59M | — | $53.03 | $48.04 (−9%) | 2026-03-31 |
| PRME Prime Medicine, Inc. Common Stock | 1.4% | 16.6M | $58M | — | $10.66 | $3.06 (−71%) | 2026-03-31 |
| LIFE Ethos Technologies Inc. Class A Common Stock | 1.1% | 3.8M | $42M | NEW (+3.8M) | $11.17 | $33.54 (+200%) | 2026-03-31 |
| MAZE Maze Therapeutics, Inc. Common Stock | 1.0% | 1.4M | $41M | — | $11.01 | $27.22 (+147%) | 2026-03-31 |
| BBOT BridgeBio Oncology Therapeutics, Inc. Common Stock | 0.6% | 2.8M | $25M | — | $11.58 | $4.07 (−65%) | 2026-03-31 |
| RLAY Relay Therapeutics, Inc. Common Stock | 0.4% | 1.6M | $16M | — | $12.56 | $18.50 (+47%) | 2026-03-31 |
| GLUE Monte Rosa Therapeutics, Inc. Common Stock | 0.3% | 684K | $11M | ▼ 8.1% (−61K) | $7.79 | $11.46 (+47%) | 2026-03-31 |
| VERA Vera Therapeutics, Inc. Class A Common Stock | 0.2% | 241K | $10M | — | $7.76 | $32.23 (+315%) | 2026-03-31 |
| SANA Sana Biotechnology, Inc. Common Stock | 0.2% | 2.8M | $8M | — | $3.27 | $2.92 (−11%) | 2026-03-31 |
| BEAM Beam Therapeutics Inc. Common Stock | 0.2% | 322K | $8M | — | $30.62 | $24.45 (−20%) | 2026-03-31 |
| LYEL Lyell Immunopharma, Inc. Common Stock | 0.1% | 293K | $6M | — | $8.84 | $9.97 (+13%) | 2026-03-31 |
| OSCR Oscar Health, Inc. | 0.1% | 482K | $6M | — | $8.03 | $30.79 (+283%) | 2026-03-31 |
| FIG Figma, Inc. | 0.1% | 216K | $5M | — | $51.87 | $21.66 (−58%) | 2026-03-31 |
| SPRO Spero Therapeutics, Inc. Common Stock | 0.1% | 890K | $2M | — | $1.45 | $1.21 (−17%) | 2026-03-31 |
| HYPR Hyperfine, Inc. Class A Common Stock | 0.0% | 899K | $971K | — | $1.44 | $0.80 (−44%) | 2026-03-31 |
| AUTL Autolus Therapeutics Plc | 0.0% | 698K | $964K | — | $1.84 | $1.90 (+3%) | 2026-03-31 |
| TNYA Tenaya Therapeutics, Inc. Common Stock | 0.0% | 916K | $632K | — | $2.85 | $0.60 (−79%) | 2026-03-31 |
FAQ ▾
What are Alphabet Inc's largest holdings?
As of the latest 13F: CME Group Inc. 25.6%, Planet Labs PBC 24.5%, AST SpaceMobile, Inc. Class A Common Stock 18.5%, Revolution Medicines, Inc. Common Stock 8.0%, Arm Holdings Plc 7.4%.
How big is Alphabet Inc's 13F portfolio?
$4.0B across 26 disclosed U.S.-equity positions.
What is Alphabet Inc's 3-year performance?
+155% (13F-replication, price return), +76 pts vs the S&P 500. Not an audited fund return.
Where does this data come from?
U.S. SEC Form 13F-HR institutional holdings filings.
Sourced from SEC Form 13F-HR filings · Not investment advice ▾
Latest activity = change vs. the prior 13F. Avg buy price = est. entry over the trailing 3 years (gain = vs. latest price). Returns are 13F-replication, not audited fund returns. Sourced from SEC 13F filings.